Salicylhydroxamic Acid, with the CAS number 89 - 73 - 6, is a chemical compound offered by our factory at a low price. Its molecular formula is C₇H₇NO₃, and the molecular weight is approximately 153.13 g/mol. The appearance of this product is usually a white to off - white crystalline powder. It has a melting point ranging from 95 - 98°C. This product is slightly soluble in water and more soluble in organic solvents such as ethanol and acetone. The purity of our factory - supplied salicylhydroxamic acid can be guaranteed to meet high - quality standards, which is ideal for various industrial and laboratory applications.
Salicylhydroxamic Acid has a wide range of uses. In the field of metallurgy, it is commonly used as a flotation collector. It can effectively separate metal minerals from gangue minerals, especially for the flotation of tungsten, tin, and rare earth minerals. By selectively binding to the surface of metal minerals, it changes the hydrophobicity of the mineral surface, allowing the metal minerals to be easily captured by air bubbles and separated in the flotation process.
In the pharmaceutical industry, salicylhydroxamic acid shows potential as an anti - cancer agent. It can inhibit the activity of certain enzymes related to tumor growth, thereby reducing the proliferation and metastasis of cancer cells. Additionally, it has antibacterial and anti - inflammatory properties, which may be used in the development of new drugs for the treatment of various infections and inflammatory diseases.
In the field of chemical synthesis, it can be used as an intermediate for the synthesis of other complex organic compounds. Its unique chemical structure allows it to participate in a variety of chemical reactions, such as condensation reactions and substitution reactions, to form new compounds with specific functions.
When using salicylhydroxamic acid as a flotation collector, it is usually necessary to prepare an appropriate concentration of solution first. The specific concentration depends on the type of ore, the content of target minerals, and the flotation conditions. Generally, a solution with a concentration of 1 - 5 g/L is prepared by dissolving the powder in water or an appropriate organic solvent. Then, the prepared solution is added to the flotation pulp at a certain rate during the flotation process, and the flotation operation is carried out according to the standard procedures.
In the pharmaceutical research and development process, the appropriate dosage form needs to be designed according to the specific application. For in vitro experiments, appropriate solvents are used to dissolve the compound to prepare a solution with a certain concentration for cell culture and other experiments. For in vivo experiments, it may need to be formulated into capsules, tablets, or injections according to the requirements of animal models or human trials.
In chemical synthesis, it is necessary to follow the reaction conditions and procedures of specific chemical reactions. Usually, it needs to react with other reagents in an appropriate solvent under a certain temperature and pH conditions. Appropriate catalysts may also be required to improve the reaction rate and yield.
Case 1: In a tungsten ore flotation plant, the traditional flotation collector had low efficiency in separating tungsten minerals from gangue minerals. After replacing it with our factory - supplied salicylhydroxamic acid, the recovery rate of tungsten minerals increased from 60% to 80%. By adjusting the dosage and flotation conditions, the quality of the tungsten concentrate also improved significantly, with the grade of tungsten increasing from 30% to 50%. This not only increased the economic benefits of the mine but also reduced the waste of resources.
Case 2: A pharmaceutical research team conducted in vitro experiments on salicylhydroxamic acid against a certain type of cancer cells. After treating the cancer cells with a solution of salicylhydroxamic acid at a concentration of 10 μM for 48 hours, the proliferation rate of cancer cells decreased by 50% compared with the control group. Further in vivo experiments on animal models also showed that the growth of tumors was significantly inhibited after the injection of salicylhydroxamic acid - based drugs, which provided strong evidence for its potential as an anti - cancer drug.
If you have any questions or need further information
This is William, CEO of Zhishang Chemical Co., Ltd.
Welcome to visit our factory . As the top chemical manufacturer, we have been striving for product quality, innovation , R&D, and customer service for the past 7 years. In the next 10 years or even longer, we are committed to becoming the most reliable chemical supplier in the world , creating a well-known international brand trusted by customers, with the spirit of “one meter wide, ten thousand meters deep”, we continue to focus on product research and development, continue to focus on customer service, continue to improve the supply chain service system, to create a professional chemical supply service team, to achieve win-win long-term cooperation. Please feel free to contact us if you have any questions.
English (United States) 
English (Australia) 
Portuguese 
Spanish